Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Invested Capital (2022 - 2025)

CervoMed's Invested Capital history spans 9 years, with the latest figure at $26.0 million for Q3 2025.

  • For Q3 2025, Invested Capital fell 43.0% year-over-year to $26.0 million; the TTM value through Sep 2025 reached $26.0 million, down 43.0%, while the annual FY2024 figure was $39.2 million, 431.43% up from the prior year.
  • Invested Capital for Q3 2025 was $26.0 million at CervoMed, down from $33.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $109.3 million in Q2 2024 and bottomed at -$35.1 million in Q2 2023.
  • The 4-year median for Invested Capital is $26.0 million (2025), against an average of $15.5 million.
  • The largest annual shift saw Invested Capital plummeted 210.22% in 2023 before it skyrocketed 431.43% in 2024.
  • A 4-year view of Invested Capital shows it stood at -$33.3 million in 2022, then surged by 122.16% to $7.4 million in 2023, then surged by 431.43% to $39.2 million in 2024, then tumbled by 33.65% to $26.0 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Invested Capital are $26.0 million (Q3 2025), $33.4 million (Q2 2025), and $34.6 million (Q1 2025).